These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29183000)

  • 21. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
    J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
    Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
    Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
    Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
    Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
    Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
    World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of E-cadherins in development of lymphatic tumor emboli.
    Gupta A; Deshpande CG; Badve S
    Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    Ko H; Shin J; Lee JE; Nam SJ; Nguyen TL; Hopper JL; Song YM
    BMC Cancer; 2017 Dec; 17(1):821. PubMed ID: 29207971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IQ-domain GTPase-activating protein 1 promotes the malignant phenotype of invasive ductal breast carcinoma via canonical Wnt pathway.
    Zhao HY; Han Y; Wang J; Yang LH; Zheng XY; Du J; Wu GP; Wang EH
    Tumour Biol; 2017 Jun; 39(6):1010428317705769. PubMed ID: 28618949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer].
    Zhou L; Zhao YH; Wang XD; Jiang SF; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):228-33. PubMed ID: 25924435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
    Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
    Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [BILATERAL NON-SIMULTANEOUS CARCINOMA OF THE BREAST].
    PASI PL; LONGO OA
    Prensa Med Argent; 1963 Jan; 50():273-7. PubMed ID: 14052440
    [No Abstract]   [Full Text] [Related]  

  • 33. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.
    Molland JG; Donnellan M; Janu NC; Carmalt HL; Kennedy CW; Gillett DJ
    Breast; 2004 Oct; 13(5):389-96. PubMed ID: 15454194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma apolipoprotein A1 levels at diagnosis are independent prognostic factors in invasive ductal breast cancer.
    Lin X; Hong S; Huang J; Chen Y; Chen Y; Wu Z
    Discov Med; 2017 Apr; 23(127):247-258. PubMed ID: 28595037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
    Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
    Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
    Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
    Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
    Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservative surgery for infiltrating lobular breast carcinoma.
    Salvadori B; Biganzoli E; Veronesi P; Saccozzi R; Rilke F
    Br J Surg; 1997 Jan; 84(1):106-9. PubMed ID: 9043471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classifying the Progression of Ductal Carcinoma from Single-Cell Sampled Data via Integer Linear Programming: A Case Study.
    Catanzaro D; Shackney SE; Schaffer AA; Schwartz R
    IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(4):643-55. PubMed ID: 26353381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.